Accuracy of traditional and novel serology tests for predicting cross-protection in foot-and-mouth disease vaccinated cattle

Vaccine

Volumn 32, Issue 4, 2014, Pages 433-436

  Brito, Bárbara Patricia ^a   Perez, Andrés Maximiliano ^a,b   Capozzo, Alejandra Victoria ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Universidad Nacional de Río Cuarto Consejo Nacional de Investigaciones Científicas y Técnicas   (Argentina)

^c INSTITUTO NACIONAL DE TECNOLOGÍA AGROPECUARIA INTA   (Argentina)

Author keywords

Cattle; Foot and mouth disease; Serology; Vaccine matching

Indexed keywords

FOOT AND MOUTH DISEASE VACCINE; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; CATTLE; CROSS PROTECTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; GOLD STANDARD; HETEROLOGOUS IGG1; HETEROLOGOUS IGG1 IGG2 RATIO; IN VIVO STUDY; INTERMETHOD COMPARISON; NONHUMAN; PODAL GENERALIZATION; PREDICTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEROLOGY; VIRUS NEUTRALIZATION; VIRUS STRAIN;

CATTLE; FOOT-AND-MOUTH DISEASE; SEROLOGY; VACCINE MATCHING;

ANIMALS; ANTIBODIES, VIRAL; ANTIBODY AFFINITY; ANTIBODY FORMATION; CATTLE; CATTLE DISEASES; CROSS PROTECTION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; IMMUNOGLOBULIN G; NEUTRALIZATION TESTS; ROC CURVE; SENSITIVITY AND SPECIFICITY; VIRAL VACCINES;

EID: 84891635506     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.12.007     Document Type: Article

References (12)

1. Bolwell C., Parry N.R., Rowlands D.J. Comparison between in vitro neutralization titres and in vivo protection against homologous and heterologous challenge induced by vaccines prepared from two serologically distinct variants of foot-and-mouth disease virus, serotype A22. J Gen Virol 1992, 73(Pt 3):727-731.
2. Brehm K.E., Kumar N., Thulke H.H., Haas B. High potency vaccines induce protection against heterologous challenge with foot-and-mouth disease virus. Vaccine 2008, 26:1681-1687.
3. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas 1960, 20:37-46.
4. Goris N., Maradei E., D'Aloia R., Fondevila N., Mattion N., Perez A., et al. Foot-and-mouth disease vaccine potency testing in cattle using homologous and heterologous challenge strains: precision of the protection against podal generalisation test. Vaccine 2008, 26:3432-3437.
5. Goris N., Merkelbach-Peters P., Diev V.I., Verloo D., Zakharov V.M., Kraft H.P., et al. European Pharmacopoeia foot-and-mouth disease vaccine potency testing in cattle: between test variability and its consequences. Vaccine 2007, 25:3373-3379.
6. Lavoria M.A., Di-Giacomo S., Bucafusco D., Franco-Mahecha O.L., Perez-Filgueira D.M., Capozzo A.V. Avidity and subtyping of specific antibodies applied to the indirect assessment of heterologous protection against foot-and-mouth disease virus in cattle. Vaccine 2012, 30:6845-6850.
7. Mattion N., Goris N., Willems T., Robiolo B., Maradei E., Beascoechea C.P., et al. Some guidelines for determining foot-and-mouth disease vaccine strain matching by serology. Vaccine 2009, 27:741-747.
8. Nagendrakumar S.B., Srinivasan V.A., Madhanmohan M., Yuvaraj S., Parida S., Di Nardo A., et al. Evaluation of cross-protection between O1 Manisa and O1 Campos in cattle vaccinated with foot-and-mouth disease virus vaccine incorporating different payloads of inactivated O1 Manisa antigen. Vaccine 2011, 29:1906-1912.
9. OIE, W.O.f.A.H. Foot-and-mouth disease. Manual of Diagnostic Tests and Vaccines for Terrestrial Animals 2012, OIE, [chapter 2.1.5].
10. Robiolo B., La Torre J., Maradei E., Beascoechea C.P., Perez A., Seki C., et al. Confidence in indirect assessment of foot-and-mouth disease vaccine potency and vaccine matching carried out by liquid phase ELISA and virus neutralization tests. Vaccine 2010, 28:6235-6241.
11. Sing T., Sander O., Beerenwinkel N., Lengauer T. ROCR: visualizing classifier performance in R. Bioinformatics 2005, 21:3940-3941.
12. Willems T., Lefebvre D.J., Goris N., Diev V.I., Kremenchugskaya S.R., Paul G., et al. Characteristics of serology-based vaccine potency models for foot-and-mouth disease virus. Vaccine 2012, 30:5849-5855.